Warner Bros. Discovery, Inc.
CYCLOPROPYLAMINE COMPOUND AS LSD1 INHIBITOR AND USE THEREOF

Last updated:

Abstract:

Provided is a cyclopropylamine compound as lysine-specific demethylase 1 (LSD1) inhibitor, and a use thereof in preparation of drug for treating diseases associated with LSD1. The cyclopropylamine compound is a compound represented by formula (I), an isomer thereof, and a pharmaceutically acceptable salt thereof. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

12 Sep 2019

Issue date:

21 Apr 2022